Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation
about
Expression of the TCL1 gene at 14q32 in B-cell malignancies but not in adult T-cell leukemiaIn multiple myeloma, 14q32 translocations are nonrandom chromosomal fusions driving high expression levels of the respective partner genes.Expression of constitutively nuclear cyclin D1 in murine lymphocytes induces B-cell lymphoma.Cyclin D1 amplification and expression in human breast carcinoma: correlation with histological prognostic markers and oestrogen receptor expression.The biology of human lymphoid malignancies revealed by gene expression profiling.Elevation of cell cycle control proteins during spontaneous immortalization of human keratinocytes.Function of a human cyclin gene as an oncogene.API2-MALT1 fusion transcripts involved in mucosa-associated lymphoid tissue lymphoma: multiplex RT-PCR detection using formalin-fixed paraffin-embedded specimensExpression of retinoblastoma gene product (pRb) in mantle cell lymphomas. Correlation with cyclin D1 (PRAD1/CCND1) mRNA levels and proliferative activityAPI2-MALT1 chimeric transcripts involved in mucosa-associated lymphoid tissue type lymphoma predict heterogeneous products.Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14).Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survivalPrognostic significance of CCND1 (cyclin D1) overexpression in primary resected non-small-cell lung cancer.BCL-6 and other genomic alterations in non-Hodgkin's lymphoma (NHL).Molecular cloning of 19p13 breakpoint region in infantile leukemia with t(11;19)(q23;p13) translocation.Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia.Differential tumorigenicity between Epstein-Barr virus genome-positive and genome-negative cell lines with t(11;14)(q13;q32) derived from mantle cell lymphoma.EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus.Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.Monoclonal antibody against PRAD1/cyclin D1 stains nuclei of tumor cells with translocation or amplification at BCL-1 locus.Skin manifestations associated with mantle cell lymphoma: a case report.Acceleration of the G1/S phase transition by expression of cyclins D1 and E with an inducible system.Multiple myeloma: increasing evidence for a multistep transformation process.Absence of RET proto-oncogene point mutations in sporadic hyperplastic and neoplastic lesions of the parathyroid glandProtein expression of cell cycle regulator, p27Kip1, correlates with histopathological grade of non-Hodgkin's lymphoma.MUM1/IRF4 expression is an unfavorable prognostic factor in B-cell chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).Immunohistochemical analysis of cyclin D1 protein in hematopoietic neoplasms with special reference to mantle cell lymphoma.Infrequent BCL10 mutations in B-cell non-Hodgkin's lymphomas.The positive nuclear staining observed with monoclonal antibody against PRAD1/cyclin D1 correlates with mRNA expression in mantle cell lymphoma.Somatic hypermutations in the VH segment of immunoglobulin genes of CD5-positive diffuse large B-cell lymphomas.
P2860
Q28282628-5C63D510-CE30-4A3D-A399-8809C5DD139CQ33590961-8D557E8D-BEC5-48A4-9B9A-C5939143D5EFQ33706095-AE55AF97-602F-4297-B3F2-988F391C139AQ33840107-5009EF8B-FB1F-4FEC-973E-D3EE4FB5A6D2Q34313320-52B054AE-7863-4A6F-A0E7-ADE14BCA0675Q34435745-0ED1C549-5760-4CEB-8168-AD858C38C4AEQ34994859-2E0F08E4-60E8-4121-ABCC-20C643F96BA4Q35746352-A6F74E9B-F334-45CE-8D03-B390030ED647Q35773697-73AFCA5E-80D0-4FE9-BAE7-5A221448900CQ35809909-643D3931-6136-4511-92B8-41B491B2274CQ35810205-1F075950-3D29-4632-AE4F-38CF1C82D775Q35828800-C236AA1B-82D3-4C8B-87FA-26D05B7F7380Q36134992-D5D5373F-DA30-430D-BA86-A57F70AF129CQ36421709-C902806F-BBB1-451B-870C-266F32EAB655Q36763920-1893DAC1-3EFC-47BA-B112-03A2457057BBQ37429299-49238DA9-7103-4F9F-92BA-88189AF0A9C0Q39877438-DC14EB32-F110-4566-9AB6-9725F9C1A118Q40792597-233AB338-D7B1-4829-96CC-B85352C39837Q40792693-6F0D1F72-393C-4503-AFF0-3CA55194A309Q41444722-0A6CC9A6-4350-4F81-8FF1-1DC3D9CD9CDEQ41476727-CDCE95D2-9127-4F18-8A59-D1DC5B5FA1F5Q41483751-97BC35A4-3185-470C-99FE-819AAE19B6EBQ41670812-2565C19B-0231-4036-A375-B7371F62B700Q42025078-D1BF58AE-3EA4-4997-9B0C-FEA7F3F4A48EQ44453229-B556BCF1-009E-47CF-8B97-FAF4BF53EF13Q54698123-997AC641-779A-46CC-97E2-AB77F896563DQ55026872-132F7AA2-7924-49BD-BF4B-A04BFC58DF89Q55111621-20721445-E712-406A-B8B1-B24B51B10352Q55237298-0CA2D593-C5B2-4837-8689-A9A05827D0F9Q55339979-0FD432A5-23E7-4CCC-BCB1-289A21D55C83
P2860
Gene rearrangement and overexpression of PRAD1 in lymphoid malignancy with t(11;14)(q13;q32) translocation
description
1992 nî lūn-bûn
@nan
1992 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
name
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@ast
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@en
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@nl
type
label
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@ast
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@en
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@nl
prefLabel
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@ast
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@en
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@nl
P2093
P1433
P1476
Gene rearrangement and overexp ...... (11;14)(q13;q32) translocation
@en
P2093
I Kubonishi
K R Utsumi
K Yamamoto
P304
P407
P577
1992-07-01T00:00:00Z